Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Birociclib in Solid Tumors and Advanced Breast Cancer
NCT04539496Phase 2Active, not recruiting
- Sponsor
- Sihuan Pharmaceutical
- Start
- May 2018
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of birociclib in solid tumor, breast cancer, sponsored by Sihuan Pharmaceutical. Started May 2018; status: active, not recruiting.
02
Drugs
birociclib
03
Conditions
solid tumorbreast cancer
Beyond the preview
Go deeper on NCT04539496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04539496.